Clinical trial
A Pilot Study to Evaluate the Clinical and Biological Tolerance of Sitagliptin With Pegylated Interferon alfa2a Plus Ribavirin Combination Therapy in Chronic Hepatitis C Patients
NCT01567540 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate the Clinical and Biological Tolerance of Sitagliptin With Pegylated Interferon alfa2a Plus Ribavirin Combination Therapy in Chronic Hepatitis C Patients
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- March 31, 2013
- Completion date
- January 31, 2014
- Enrollment
- 3 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.